Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · IEX Real-Time Price · USD
42.55
-0.23 (-0.54%)
At close: Jul 19, 2024, 4:00 PM
42.50
-0.05 (-0.12%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Ultragenyx Pharmaceutical Market Cap
Ultragenyx Pharmaceutical has a market cap or net worth of $3.85 billion as of July 22, 2024. Its market cap has increased by 19.55% in one year.
Market Cap
3.85B
Enterprise Value
3.48B
1-Year Change
19.55%
Ranking
Category
Stock Price
$42.55
Market Cap Chart
Since January 31, 2014, Ultragenyx Pharmaceutical's market cap has increased from $1.19B to $3.85B, an increase of 224.14%. That is a compound annual growth rate of 11.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 3.54B | -9.92% |
| Dec 29, 2023 | 3.93B | 20.90% |
| Dec 30, 2022 | 3.25B | -43.33% |
| Dec 31, 2021 | 5.73B | -32.17% |
| Dec 31, 2020 | 8.45B | 242.48% |
| Dec 31, 2019 | 2.47B | 12.20% |
| Dec 31, 2018 | 2.20B | 11.33% |
| Dec 29, 2017 | 1.98B | -31.24% |
| Dec 30, 2016 | 2.87B | -34.05% |
| Dec 31, 2015 | 4.36B | 211.25% |
| Dec 31, 2014 | 1.40B | 17.73% |
| Jan 31, 2014 | 1.19B | - |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Crinetics Pharmaceuticals | 4.13B |
| Integer Holdings | 4.13B |
| Inspire Medical Systems | 4.09B |
| Dyne Therapeutics | 4.05B |
| Axsome Therapeutics | 3.90B |
| Guardant Health | 3.81B |
| Perrigo Company | 3.77B |
| Sotera Health Company | 3.75B |